Literature DB >> 8284641

Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients.

A Li1, Z C Rong, E Ekwall, U Forsum, A A Lindberg.   

Abstract

Serum antibody responses to shigella lipopolysaccharide (LPS) and invasion plasmid-coded antigens (Ipa) were studied in 74 Swedish patients with culture verified bacillary dysentery using class-specific enzyme immunoassay (EIA). Anti-LPS responses were found in 80% and 79% serum samples, respectively, from S. flexneri and S. sonnei infected patients and anti-Ipa responses in 60% and 43%, respectively. The mean anti-Ipa IgG antibody titres in S. flexneri infected patients remained high for 4-6 months after onset while the anti-LPS IgG antibody titres had dropped to normal levels. The specificity of EIA for shigella Ipa was 90% and for S. dysenteriae, S. flexneri and S. sonnei LPSs it varied between 84% and 90%. No close correlations between the anti-LPS and anti-Ipa antibody responses were observed indicating that they may be differently regulated. The dynamics of the serum antibody responses indicates that an anti-LPS response is a good indicator of a recent shigella infection and an anti-Ipa IgG response a good indicator of a previous infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8284641     DOI: 10.3109/00365549309008545

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

1.  Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD).

Authors:  K R Turbyfill; J A Mertz; C P Mallett; E V Oaks
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Vaccines against gastroenteritis, current progress and challenges.

Authors:  Hyesuk Seo; Qiangde Duan; Weiping Zhang
Journal:  Gut Microbes       Date:  2020-06-18

3.  Immune response to Shigella sonnei in U.S. Marines.

Authors:  M M Mikhail; M M Mansour; B A Oyofo; J D Malone
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

4.  Antibody response of monkeys to invasion plasmid antigen D after infection with Shigella spp.

Authors:  E V Oaks; W D Picking; W L Picking
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

5.  Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine.

Authors:  K R Turbyfill; A B Hartman; E V Oaks
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 6.  From Concept to Clinical Product: A Brief History of the Novel Shigella Invaplex Vaccine's Refinement and Evolution.

Authors:  K Ross Turbyfill; Kristen A Clarkson; Edwin V Oaks; Robert W Kaminski
Journal:  Vaccines (Basel)       Date:  2022-04-01

7.  Immunoproteome analysis of soluble and membrane proteins of Shigella flexneri 2457T.

Authors:  Amy V Jennison; Rubhana Raqib; Naresh K Verma
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  Recognition of three epitopic regions on invasion plasmid antigen C by immune sera of rhesus monkeys infected with Shigella flexneri 2a.

Authors:  K R Turbyfill; S W Joseph; E V Oaks
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study.

Authors:  Avital A Shimanovich; Amanda D Buskirk; Shannon J Heine; William C Blackwelder; Rezwanul Wahid; Karen L Kotloff; Marcela F Pasetti
Journal:  Clin Vaccine Immunol       Date:  2017-02-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.